Branded Generics Market Expansion to USD 860.5B Forecast by 2035
The global branded generics market is forecasted to expand from USD 382.4 billion in 2025 to USD 860.5 billion by 2035, registering a CAGR of 8.4%. This growth is driven by rising healthcare expenditures and the increasing prevalence of chronic diseases, particularly in emerging economies. The branded generics market has witnessed remarkable growth over recent years, becoming a vital segment within the broader pharmaceutical industry. Branded generics refer to medicines that are off-patent but marketed under a brand name, offering a balance between affordability and perceived quality. These products serve as an essential alternative to patented drugs and unbranded generics, meeting the needs of both patients and healthcare providers who seek cost-effective treatment options without compromising on reliability. In many developing and emerging economies, branded generics play a critical role in healthcare by improving access to essential medicines at affordable prices. These m...